By Conjoint Professor Dedee Frances Murrell

Journal articles

Saleh MA; Zaraa I; Doss N; Saleh NA; Murrell DF, 2019, 'Assessment of the quality of life of Egyptian and Tunisian autoimmune bullous diseases' patients using an Arabic version of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires.', An Bras Dermatol, 94, pp. 399 - 404, http://dx.doi.org/10.1590/abd1806-4841.20197198

Guignant M; Murrell D; Schimdt E; Zillikens D; Prost C; Caux F; Joly P, 2019, 'Comment les experts internationaux traitent-ils les patients atteints de pemphigoïde bulleuse à travers le monde ?', Annales de Dermatologie et de Vénéréologie, 146, pp. A62 - A62, http://dx.doi.org/10.1016/j.annder.2019.09.039

Ferries L; Gilibert A; Alexandre M; Duvert-Lehembre S; Corbaux C; Hébert V; Prost-Squarcioni C; Caux F; Delaporte E; Litrowski N; Boulard C; Murrell D; Joly P, 2019, 'Corrélations entre les questionnaires de qualité de vie spécifiques aux maladies bulleuses auto-immunes ABQOL et TABQOL, et les scores de sévérité objectifs', Annales de Dermatologie et de Vénéréologie, 146, pp. A97 - A98, http://dx.doi.org/10.1016/j.annder.2019.09.100

Patsatsi A; Murrell DF, 2019, 'Multiple milia formation in blistering diseases', International Journal of Women's Dermatology, 5, pp. 275 - 275, http://dx.doi.org/10.1016/j.ijwd.2019.06.004

Makrgeorgou A; Leonardi-Bee J; Bath-Hextall FJ; Murrell DF; Tang MLK; Roberts A; Boyle RJ, 2018, 'Probiotics for treating eczema', Cochrane Database of Systematic Reviews, 2018, http://dx.doi.org/10.1002/14651858.CD006135.pub3

Wang EQ; Radjenovic M; Castrillón MA; Feng GHY; Murrell DF, 2018, 'The effect of autoimmune blistering diseases on work productivity', Journal of the European Academy of Dermatology and Venereology, 32, pp. 1959 - 1966, http://dx.doi.org/10.1111/jdv.15062

Murrell DF; Caux F; Prost-Squarcioni C, 2018, 'Is the Oral Disease Severity Score going to be useful for dermatologists when assessing pemphigus?', British Journal of Dermatology, 179, pp. 816 - 817, http://dx.doi.org/10.1111/bjd.16911

De Brito M; Huebner G; Murrell D; Bullpitt P; Hartmann K, 2018, 'Normocomplementaemic urticarial vasculitis: Effective treatment with omalizumab', Clinical and Translational Allergy, 8, http://dx.doi.org/10.1186/s13601-018-0222-y

Yang A; Uhlenhake E; Murrell DF, 2018, 'Pemphigoid gestationis and intravenous immunoglobulin therapy', International Journal of Women S Dermatology, 4, pp. 166 - 169, http://dx.doi.org/10.1016/j.ijwd.2018.03.007

Wang EQ; Castrillón Velásquez MA; Murrell DF, 2018, 'The effects of autoimmune blistering diseases on work productivity: A review', International Journal of Women S Dermatology, 4, pp. 131 - 138, http://dx.doi.org/10.1016/j.ijwd.2017.11.001

Cho RJ; Alexandrov LB; Den Breems NY; Atanasova VS; Farshchian M; Purdom E; Nguyen TN; Coarfa C; Rajapakshe K; Prisco M; Sahu J; Tassone P; Greenawalt EJ; Collisson EA; Wu W; Yao H; Su X; Guttmann-Gruber C; Hofbauer JP; Hashmi R; Fuentes I; Benz SC; Golovato J; Ehli EA; Davis CM; Davies GE; Covington KR; Murrell DF; Salas-Alanis JC; Palisson F; Bruckner AL; Robinson W; Has C; Bruckner-Tuderman L; Titeux M; Jonkman MF; Rashidghamat E; Lwin SM; Mellerio JE; McGrath JA; Bauer JW; Hovnanian A; Tsai KY; South AP, 2018, 'APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa', Science Translational Medicine, 10, http://dx.doi.org/10.1126/scitranslmed.aas9668

Chen G; Yang B; Zhang Z; Yang Q; Yan X; Murrell DF; Zhang F, 2018, 'Chinese version of the treatment of autoimmune bullous disease quality of life questionnaire: Reliability and validity', Indian Journal of Dermatology Venereology and Leprology, 84, pp. 431 - 436, http://dx.doi.org/10.4103/ijdvl.IJDVL_538_16

Prost-Squarcioni C; Caux F; Schmidt E; Jonkman MF; Vassileva S; Kim SC; Iranzo P; Daneshpazhooh M; Terra J; Bauer J; Fairley J; Hall R; Hertl M; Lehman JS; Marinovic B; Patsatsi A; Zillikens D; Werth V; Woodley DT; Murrell DF, 2018, 'International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita', British Journal of Dermatology, 179, pp. 30 - 41, http://dx.doi.org/10.1111/bjd.16138

Xuan RR; Yang A; Murrell DF, 2018, 'New biochip immunofluorescence test for the serological diagnosis of pemphigus vulgaris and foliaceus: A review of the literature', International Journal of Women S Dermatology, 4, pp. 102 - 108, http://dx.doi.org/10.1016/j.ijwd.2017.10.001

Lee BWH; Tan JCK; Radjenovic M; Coroneo MT; Murrell DF, 2018, 'A review of scoring systems for ocular involvement in chronic cutaneous bullous diseases', Orphanet Journal of Rare Diseases, 13, pp. 83, http://dx.doi.org/10.1186/s13023-018-0823-5

Yang A; Chin R; Murrell DF, 2018, 'Mucous membrane pemphigoid affecting the epiglottis and response to intravenous immunoglobulin therapy', Otolaryngology Case Reports, 6, pp. 1 - 3, http://dx.doi.org/10.1016/j.xocr.2017.11.001

Jain SV; Murrell DF, 2018, 'Psychosocial impact of inherited and autoimmune blistering diseases', International Journal of Women S Dermatology, 4, pp. 49 - 53, http://dx.doi.org/10.1016/j.ijwd.2017.11.004

Drucker AM; Eyerich K; de Bruin-Weller MS; Thyssen JP; Spuls PI; Irvine AD; Girolomoni G; Dhar S; Flohr C; Murrell DF; Paller AS; Guttman-Yassky E, 2018, 'Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement', British Journal of Dermatology, 178, pp. 768 - 775, http://dx.doi.org/10.1111/bjd.15928

Bauer JW; Paller A; Mellerio JE; Hovnanian A; Pan JJ; Zografaos P; Licholai GP; Murrell DF, 2018, 'Use of an Investigator's Global Assessment Scale to Evaluate Disease Severity in Patients swith Epidermolysis Bullosa Simplex', SKIN The Journal of Cutaneous Medicine, 2, pp. s55, http://dx.doi.org/10.25251/skin.2.supp.55

Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L, 2018, 'Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management', Clinical Reviews in Allergy and Immunology, 54, pp. 26 - 51, http://dx.doi.org/10.1007/s12016-017-8633-4

Yang A; Kim M; Craig P; Murrell DF, 2018, 'A case report of the use of rituximab and the epidermolysis bullosa disease activity scoring index (EBDASI) in a patient with epidermolysis bullosa acquisita with extensive esophageal involvement', Acta Dermatovenerologica Croatica, 26, pp. 325 - 328

Kim M; Li M; Intong-Wheeler LRA; Tran K; Marucci D; Murrell DF, 2018, 'Epidemiology and outcome of squamous cell carcinoma in epidermolysis bullosa in Australia and New Zealand', Acta Dermato Venereologica, 98, pp. 70 - 76, http://dx.doi.org/10.2340/00015555-2781

Lee J; Werth VP; Hall RP; Eming R; Fairley JA; Fajgenbaum DC; Harman KE; Jonkman MF; Korman NJ; Ludwig RJ; Murrell DF; Musette P; Naik HB; Sadik CD; Yamagami J; Yale ML; Payne AS, 2018, 'Perspective from the 5th international pemphigus and pemphigoid foundation scientific conference', Frontiers in Medicine, 5, http://dx.doi.org/10.3389/fmed.2018.00306

Xuan RR; Yang A; Melbourne W; Hashimoto T; Uzun S; Daneshpazhooh M; Yamagami J; Di Zenzo G; Mascaro J; Murrell D, 2018, '059 Reliability of the BIOCHIP in pemphigus and pemphigoid patients the evaluations of blistering disease experts', Journal of Investigative Dermatology, 138, pp. s10, http://dx.doi.org/10.1016/j.jid.2018.03.063

Chen J; Yang A; Murrell D, 2018, '265 Osteopenia is common in mild forms of epidermolysis bullosa', Journal of Investigative Dermatology, 138, pp. s45, http://dx.doi.org/10.1016/j.jid.2018.03.271

Murrell D; Stavropoulos P; Patsatsi A; Zeeli T; Baum S; Bassukas I; Caux F; Roussaki A; Sinclair R; Kern J; Gourlay S; Joly P, 2018, 'Anti-desmoglein levels & response to the BTK inhibitor PRN1008 in pemphigus', JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138, pp. B7 - B7, http://dx.doi.org/10.1016/j.jid.2018.06.040

Murrell DF; Daneshpahzooh M; Meymandi S; Wiest LG, 2018, 'International chapters and membership of WDS are growing', International Journal of Women's Dermatology, 4, pp. 240 - 240, http://dx.doi.org/10.1016/j.ijwd.2018.10.005

Murrell D; Paller A; Bodemer C; Barth JA; Lagast H; Reha A, 2018, 'Natural history of wound closure and other clinical endpoints in epidermolysis bullosa: Lessons from a 90-day multicenter trial', JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138, pp. S99 - S99, http://dx.doi.org/10.1016/j.jid.2018.03.593

Drucker AM; Eyerich K; de Bruin‐Weller MS; Thyssen JP; Spuls PI; Irvine AD; Girolomoni G; Dhar S; Flohr C; Murrell DF; Paller AS; Guttman‐Yassky E, 2018, 'Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement', British Journal of Dermatology, 178, pp. e232 - e232, http://dx.doi.org/10.1111/bjd.16385

Drucker AM; Eyerich K; de Bruin‐Weller MS; Thyssen JP; Spuls PI; Irvine AD; Girolomoni G; Dhar S; Flohr C; Murrell DF; Paller AS; Guttman‐Yassky E, 2018, '对过敏性皮肤炎使用全身用糖皮质激素:国际湿疹理事会共识声明', British Journal of Dermatology, 178, pp. e246 - e246, http://dx.doi.org/10.1111/bjd.16452

Frew JW; Davidson M; Murrell DF, 2017, 'Disease-specific health related quality of life patient reported outcome measures in Genodermatoses: A systematic review and critical evaluation', Orphanet Journal of Rare Diseases, 12, pp. 189, http://dx.doi.org/10.1186/s13023-017-0739-5

Gollins CE; Shipman AR; Murrell DF, 2017, 'A study of the number of female editors-in-chief of dermatology journals', International Journal of Women S Dermatology, 3, pp. 185 - 188, http://dx.doi.org/10.1016/j.ijwd.2017.03.001

Murrell D, 2017, 'New developments in the management of congenital epidermolysis bullosa', Annales De Dermatologie Et De Venereologie, 144, pp. S6 - S7, http://dx.doi.org/10.1016/j.annder.2017.09.587

Murrell DF; Sprecher E, 2017, 'Rituximab and short-course prednisone as the new gold standard for new-onset pemphigus vulgaris and pemphigus foliaceus', British Journal of Dermatology, 177, pp. 1143 - 1144, http://dx.doi.org/10.1111/bjd.15947

Kim EN; Harris AG; Bingham LJ; Yan W; Su JC; Murrell DF, 2017, 'A review of 52 pedigrees with epidermolysis bullosa simplex identifying ten novel mutations in KRT5 and KRT14 in Australia', Acta Dermato Venereologica, 97, pp. 1114 - 1119, http://dx.doi.org/10.2340/00015555-2715

Frew JW; Murrell DF, 2017, 'Highly Resistant Acrodermatitis Continua of Hallopeau and Pustular Psoriasis', Skin Appendage Disorders, 3, pp. 179 - 181, http://dx.doi.org/10.1159/000464140

Patsatsi A; Kokolios M; Kyriakou A; Lamprou F; Stylianidou D; Tsapas A; Goulis DG; Murrell DF; Sotiriadis D, 2017, 'Quality of life in greek patients with autoimmune bullous diseases assessed with ABQOL and TABQOL indexes', Acta Dermato Venereologica, 97, pp. 1145 - 1147, http://dx.doi.org/10.2340/00015555-2737

Murrell DF; Grant-Kels J, 2017, 'The International Journal of Women's Dermatology is now listed on PubMed Central', International Journal of Women S Dermatology, 3, pp. 126, http://dx.doi.org/10.1016/j.ijwd.2017.06.003

Kim E; Harris A; Hyland V; Murrell DF, 2017, 'Digenic inheritance in epidermolysis bullosa simplex involving two novel mutations in KRT5 and KRT14', British Journal of Dermatology, 177, pp. 262 - 264, http://dx.doi.org/10.1111/bjd.15053

Castrillón MA; Murrell DF, 2017, 'Lupus profundus limited to a site of trauma: Case report and review of the literature', International Journal of Women S Dermatology, 3, pp. 117 - 120, http://dx.doi.org/10.1016/j.ijwd.2017.03.002

Patsatsi A; Murrell DF, 2017, 'Multiple sclerosis is the neurological disorder most highly associated with bullous pemphigoid', British Journal of Dermatology, 176, pp. 1428 - 1429, http://dx.doi.org/10.1111/bjd.15581

Sekulic A; Migden MR; Basset-Seguin N; Garbe C; Gesierich A; Lao CD; Miller C; Mortier L; Murrell DF; Hamid O; Quevedo JF; Hou J; McKenna E; Dimier N; Williams S; Schadendorf D; Hauschild A, 2017, 'Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update of the pivotal ERIVANCE BCC study', BMC Cancer, 17, pp. 332, http://dx.doi.org/10.1186/s12885-017-3286-5

Cheape AC; Murrell DF, 2017, '2% Crisaborole topical ointment for the treatment of mild-to-moderate atopic dermatitis', Expert Review of Clinical Immunology, 13, pp. 415 - 423, http://dx.doi.org/10.1080/1744666X.2017.1304820

Smithson SL; Rademaker M; Adams S; Bade S; Bekhor P; Davidson S; Dore A; Drummond C; Fischer G; Gin A; Grills C; Halbert A; Lokmic Z; McCahon E; Morgan VA; Murrell DF; Orchard D; Penington A; Purvis D; Relic J; Robertson S; Robinson AJ; Scardamaglia L; Su J; Tan S; Wargon O; Warren L; Wong LC; Zappala T; Phillips R, 2017, 'Consensus statement for the treatment of infantile haemangiomas with propranolol', Australasian Journal of Dermatology, 58, pp. 155 - 159, http://dx.doi.org/10.1111/ajd.12600

van Beek N; Dähnrich C; Johannsen N; Lemcke S; Goletz S; Hübner F; Di Zenzo G; Dmochowski M; Drenovska K; Geller S; Horn M; Kowalewski C; Medenica L; Murrell DF; Patsatsi A; Uzun S; Vassileva S; Zillikens D; Schlumberger W; Schmidt E, 2017, 'Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases', Journal of the American Academy of Dermatology, 76, pp. 889 - 894.e5, http://dx.doi.org/10.1016/j.jaad.2016.11.002

Harris AG; Todes-Taylor NR; Petrović N; Murrell DF, 2017, 'The distribution of epidermolysis bullosa in Australia with a focus on rural and remote areas', Australasian Journal of Dermatology, 58, pp. 122 - 125, http://dx.doi.org/10.1111/ajd.12431

Zhao CY; Hao EY; Oh DD; Daniel BS; Martin LK; Su JC; Rodrigues M; Murrell DF, 2017, 'A comparison study of clinician-rated atopic dermatitis outcome measures for intermediate- to dark-skinned patients', British Journal of Dermatology, 176, pp. 985 - 992, http://dx.doi.org/10.1111/bjd.15271

Jain SV; Harris AG; Su JC; Orchard D; Warren LJ; McManus H; Murrell DF, 2017, 'The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI): grading disease severity and assessing responsiveness to clinical change in epidermolysis bullosa', Journal of the European Academy of Dermatology and Venereology, 31, pp. 692 - 698, http://dx.doi.org/10.1111/jdv.13953

Miloslavsky EM; Naden RP; Bijlsma JWJ; Brogan PA; Brown ES; Brunetta P; Buttgereit F; Choi HK; Dicaire JF; Gelfand JM; Heaney LG; Lightstone L; Lu N; Murrell DF; Petri M; Rosenbaum JT; Saag KS; Urowitz MB; Winthrop KL; Stone JH, 2017, 'Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis', Annals of the Rheumatic Diseases, 76, pp. 543 - 546, http://dx.doi.org/10.1136/annrheumdis-2016-210002

Cust AE; Murrell DF, 2017, 'Increasing prevalence but not incidence of psoriasis in the U.K.', British Journal of Dermatology, 176, pp. 568 - 569, http://dx.doi.org/10.1111/bjd.15331

Back to profile page